Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 75 results.
User Information
Export Records
  1. 1.   The Janus kinase 1 is critical for pancreatic cancer initiation and progression
  2. Shrestha, Hridaya; Rädler, Patrick D; Dennaoui, Rayane; Wicker, Madison N; Rajbhandari, Nirakar; Sun, Yunguang; Peck, Amy R; Vistisen, Kerry; Triplett, Aleata A; Beydoun, Rafic; Sterneck,Esta; Saur, Dieter; Rui, Hallgeir; Wagner, Kay-Uwe
  3. Cell Reports. 2024, May 10; 43(5): 114202.
  1. 2.   Deep learning-based segmentation of multisite disease in ovarian cancer
  2. Buddenkotte, Thomas; Rundo, Leonardo; Woitek, Ramona; Escudero Sanchez, Lorena; Beer, Lucian; Crispin-Ortuzar, Mireia; Etmann, Christian; Mukherjee, Subhadip; Bura, Vlad; McCague, Cathal; Sahin, Hilal; Pintican, Roxana; Zerunian, Marta; Allajbeu, Iris; Singh, Naveena; Sahdev, Anju; Havrilesky, Laura; Cohn, David E; Bateman, Nicholas W; Conrads, Thomas P; Darcy, Kathleen M; Maxwell, G Larry; Freymann,John; Öktem, Ozan; Brenton, James D; Sala, Evis; Schönlieb, Carola-Bibiane
  3. European Radiology Experimental. 2023, Dec 07; 7(1): 77.
  1. 3.   Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature
  2. Wong-Rolle, Abigail; Dong, Qiang; Zhu, Yunhua; Divakar, Prajan; Hor, Jyh Liang; Kedei, Noemi; Wong, Madeline; Tillo,Desiree; Conner, Elizabeth A; Rajan, Arun; Schrump, David S; Jin, Chengcheng; Germain, Ronald N; Zhao, Chen
  3. Journal for Immunotherapy of Cancer. 2022, Jul; 10(7):
  1. 4.   Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017
  2. Oehrlein, Nathan; Streicher, Samantha A; Kuo, Huai-Ching; Chaurasia, Avinash; McFadden, Jacob; Nousome,Darryl; Chen, Yongmei; Stroup, Sean P; Musser, John; Brand, Timothy; Porter, Christopher; Rosner, Inger L; Chesnut, Gregory T; Onofaro, Kayla C; Rebbeck, Timothy R; D'Amico, Anthony; Lu-Yao, Grace; Cullen, Jennifer
  3. Cancer Medicine. 2022, May 31;
  1. 5.   Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer
  2. Yerram, Nitin K.; Long, Lori; O'Connor, Luke P.; Wang, Alex Z.; Ahdoot, Michael; Lebastchi, Amir H.; Gurram, Sandeep; Zeng, Johnathan; Chalfin, Heather; Harmon,Stephanie; Mehralivand, Sherif; Merino, Maria J.; Parnes, Howard L.; Choyke, Peter L.; Shih, Joanna; Wood, Bradford J.; Turkbey, Baris; Pinto, Peter A.
  3. The Journal of Urology. 2021, May; 205(5): 1352-1358.
  1. 6.   PIRADS Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance
  2. Wang, Alex Z; O'Connor, Luke P; Yerram, Nitin K; Long, Lori; Zeng, Johnathan; Mehralivand, Sherif; Harmon,Stephanie; Lebastchi, Amir H; Ahdoot, Michael; Gomella, Patrick T; Gurram, Sandeep; Choyke, Peter L; Merino, Maria J; Shih, Joanna H; Wood, Bradford J; Turkbey, Baris; Pinto, Peter A
  3. The Journal of urology. 2020, DEC; 204(6): 1229-1234.
  1. 7.   Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis
  2. Beer, Lucian; Sahin, Hilal; Bateman, Nicholas W; Blazic, Ivana; Vargas, Hebert Alberto; Veeraraghavan, Harini; Kirby,Justin; Fevrier-Sullivan,Brenda; Freymann,John; Jaffe, C Carl; Brenton, James; Miccó, Maura; Nougaret, Stephanie; Darcy, Kathleen M; Maxwell, G Larry; Conrads, Thomas P; Huang, Erich; Sala, Evis
  3. European radiology. 2020, Apr 06; pii: 10.1007/s00330-020-06755-3.
  1. 8.   Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
  2. Abdul Sater, Houssein; Marté, Jennifer L; Donahue, Renee N; Walter-Rodriguez, Beatriz; Heery, Christopher R; Steinberg, Seth M; Cordes, Lisa M; Chun, Guinevere; Karzai, Fatima; Bilusic, Marijo; Harmon,Stephanie; Turkbey, Ismail Baris; Choyke, Peter L; Schlom, Jeffrey; Dahut, William L; Madan, Ravi A; Pinto, Peter A; Gulley, James L
  3. Journal for immunotherapy of cancer. 2020, Mar; 8(1): pii : jitc-2020-000655.
  1. 9.   Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia
  2. Barth, Brian M; Wang, Weiyuan; Toran, Paul T; Fox, Todd E; Annageldiyev, Charyguly; Ondrasik, Regina M; Keasey, Nicole R; Brown, Timothy J; Devine, Viola G; Sullivan, Emily C; Cote, Andrea L; Papakotsi, Vasiliki; Tan, Su-Fern; Shanmugavelandy, Sriram S; Deering, Tye G; Needle, David B; Stern,Steve; Zhu, Junjia; Liao, Jason; Viny, Aaron D; Feith, David J; Levine, Ross L; Wang, Hong-Gang; Loughran, Thomas P; Sharma, Arati; Kester, Mark; Claxton, David F
  3. Blood advances. 2019, Sep 10; 3(17): 2598-2603.
  1. 10.   Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents
  2. Czarniecki, Marcin; Mena, Esther; Lindenberg, Liza; Cacko, Marek; Harmon, Stephanie; Radtke, Jan Philipp; Giesel, Frederick; Turkbey, Baris; Choyke, Peter L.
  3. Translational andrology and urology. 2018, Oct; 7(5): 831-843.
  1. 11.   Genetic predisposition to kidney cancer
  2. Schmidt, Laura; Linehan, W. Marston
  3. SEMINARS IN ONCOLOGY. 2016, Oct; 43(5): 566-574.
  1. 12.   Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells
  2. Caropreso, V.; Darvishi, E.; Turbyville, T. J.; Ratnayake, R.; Grohar, P. J.; McMahon, J. B.; Woldemichael, G. M.
  3. The Journal of biological chemistry. 2016, 6-May; 291(19): 10058-66.
  1. 13.   Configuration-dependent Presentation of Multivalent IL-15:IL-15Ralpha Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity
  2. Hong, E.; Usiskin, I. M.; Bergamaschi, C.; Hanlon, D. J.; Edelson, R. L.; Justesen, S.; Pavlakis, G. N.; Flavell, R. A.; Fahmy, T. M.
  3. The Journal of biological chemistry. 2016, 22-Apr; 291(17): 8931-50.
  1. 14.   Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
  2. Reshma, R. S.; Sreelatha, K. H.; Somasundaram, V.; Satheesh Kumar, S.; Nadhan, R.; Nair, R. S.; Srinivas, P.
  3. Pharmacological Research. 2016, Mar; 105: 134-45.
  1. 15.   Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents
  2. Devkota, L.; Lin, C. M.; Strecker, T. E.; Wang, Y.; Tidmore, J. K.; Chen, Z.; Guddneppanavar, R.; Jelinek, C. J.; Lopez, R.; Liu, L.; Hamel, E.; Mason, R. P.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.
  3. Bioorganic & Medicinal Chemistry. 2016, 1-Mar; 24(5): 938-56.
  1. 16.   Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium
  2. Gaudet, M. M.; Barrdahl, M.; Lindstrom, S.; Travis, R. C.; Auer, P. L.; Buring, J. E.; Chanock, S. J.; Eliassen, A. H.; Gapstur, S. M.; Giles, G. G.; Gunter, M.; Haiman, C.; Hunter, D. J.; Joshi, A. D.; Kaaks, R.; Khaw, K. T.; Lee, I. M.; Le March, L.; Milne, R. L.; Peeters, P. H.; Sund, M.; Tamimi, R.; Trichopoulou, A.; Weiderpass, E.; Yang, X. R.; Prentice, R. L.; Feigelson, H. S.; Canzian, F.; Kraft, P.
  3. Breast Cancer Research and Treatment. 2016, Feb; 155(3): 531-40.
  1. 17.   Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B approximately FIT Cohort
  2. Dallal, C. M.; Lacey, J. V., Jr.; Pfeiffer, R. M.; Bauer, D. C.; Falk, R. T.; Buist, D. S.; Cauley, J. A.; Hue, T. F.; LaCroix, A. Z.; Tice, J. A.; Veenstra, T. D.; Xu, X.; Brinton, L. A.
  3. Hormones & Cancer. 2016, Feb; 7(1): 49-64.
  1. 18.   Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis
  2. Bode, C.; Kinjo, T.; Alvord, W. G.; Klinman, D. M.
  3. Carcinogenesis. 2014, May; 35(5): 1078-83.
  1. 19.   Cancer stem cells: a systems biology view of their role in prognosis and therapy
  2. Mertins, S. D.
  3. Anti-Cancer Drugs. 2014, Apr; 25(4): 353-67.
  1. 20.   Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue
  2. Shi, J.; Marconett, C. N.; Duan, J.; Hyl, P. L.; Li, P.; Wang, Z.; Wheeler, W.; Zhou, B.; Campan, M.; Lee, D. S.; Huang, J.; Zhou, W.; Triche, T.; Amundadottir, L.; Warner, A.; Hutchinson, A.; Chen, P. H.; Chung, B. S.; Pesatori, A. C.; Consonni, D.; Bertazzi, P. A.; Bergen, A. W.; Freedman, M.; Siegmund, K. D.; Berman, B. P.; Borok, Z.; Chatterjee, N.; Tucker, M. A.; Caporaso, N. E.; Chanock, S. J.; Laird-Offringa, I. A.; Landi, M. T.
  3. Nature Communications. 2014, 27-Feb; 5: 3365.
  1. 21.   Transforming growth factor beta in cancer: Janus, the two-faced god
  2. Salomon, D.
  3. Journal of the National Cancer Institute. 2014, Feb; 106(2): djt441.
  1. 22.   The importance of Raf dimerization in cell signaling
  2. Freeman, A. K.; Ritt, D. A.; Morrison, D. K.
  3. Small GTPases. 2013, Jul-Sep; 4(3): 180-5.
  1. 23.   Invited Commentary: More Surprises From a Gene Desert
  2. Wacholder, S.; Yeager, M.; Liao, L. M.
  3. American Journal of Epidemiology. 2012, Mar; 175(6): 488-491.
  1. 24.   Multiparametric 3T Prostate Magnetic Resonance Imaging to Detect Cancer: Histopathological Correlation Using Prostatectomy Specimens Processed in Customized Magnetic Resonance Imaging Based Molds
  2. Turkbey, B.; Mani, H.; Shah, V.; Rastinehad, A. R.; Bernardo, M.; Pohida, T.; Pang, Y. X.; Daar, D.; Benjamin, C.; McKinney, Y. L.; Trivedi, H.; Chua, C.; Bratslavsky, G.; Shih, J. H.; Linehan, W. M.; Merino, M. J.; Choyke, P. L.; Pinto, P. A.
  3. Journal of Urology. 2011, Nov; 186(5): 1818-1824.
  1. 25.   Genetically engineered mouse models in cancer research
  2. Walrath, J. C.; Hawes, J. J.; Van Dyke, T.; Reilly, K. M.
  3. Advances in cancer research. 2010, Apr 16; 106: 113-64.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel